Literature DB >> 2799890

Estimating the incubation time distribution and expected number of cases of transfusion-associated acquired immune deficiency syndrome.

J D Kalbfleisch1, J F Lawless.   

Abstract

The number of cases of transfusion-associated acquired immune deficiency syndrome (TA-AIDS) that will be seen over the next few years is difficult to estimate, because of the uncertainty about the number of persons infected with the human immunodeficiency virus (HIV) via blood transfusion and about the duration of the incubation period from HIV infection via transfusion to diagnosis of AIDS. Presented here are a mathematical model and nonparametric and parametric statistical analyses of recent data on TA-AIDS that indicate clearly the existing estimability problems. The methods provide short-term projections of new TA-AIDS cases to be reported; the results suggest about 1100 new cases to be reported in the United States between July 1988 and June 1989 and about 1500 more between July 1989 and June 1990. Estimates of the number of eventual TA-AIDS cases to be seen are considerably more uncertain and require additional assumptions about the incubation distribution. Under the assumption that the probability of an infected person developing AIDS within 8 years of infection is 0.40 (an estimation derived from cohort studies in homosexual men and hemophiliacs), parametric and nonparametric analyses give, respectively, point estimates of 14,300 and 15,000 for the number of eventual cases of AIDS (in the age group 13-69) attributable to infection by blood transfusion prior to July 1985. The parametric analysis gives a corresponding 95 percent confidence interval.

Entities:  

Mesh:

Year:  1989        PMID: 2799890     DOI: 10.1046/j.1537-2995.1989.29890020437.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


  8 in total

Review 1.  Haematology.

Authors:  N T O'Connor
Journal:  Postgrad Med J       Date:  1990-08       Impact factor: 2.401

2.  A meta-analysis of estimates of the AIDS incubation distribution.

Authors:  P C Cooley; L E Myers; D N Hamill
Journal:  Eur J Epidemiol       Date:  1996-06       Impact factor: 8.082

3.  Use of intravenous immunoglobulin in critically ill patients.

Authors:  Summer Donovan; Gonzalo M L Bearman
Journal:  Curr Infect Dis Rep       Date:  2014-12       Impact factor: 3.725

4.  Evolution of the residual risk of HBV, HCV and HIV transmission through blood transfusion in the Region of Valencia, Spain, during a 15-year period (2003-2017).

Authors:  Carlos López-Menchero; Manuel Alvarez; Pascual Fernández; María Guzmán; María I Ortiz-de-Salazar; Cristina Arbona
Journal:  Blood Transfus       Date:  2019-11       Impact factor: 3.443

5.  Modelers' perception of mathematical modeling in epidemiology: a web-based survey.

Authors:  Gilles Hejblum; Michel Setbon; Laura Temime; Sophie Lesieur; Alain-Jacques Valleron
Journal:  PLoS One       Date:  2011-01-31       Impact factor: 3.240

6.  Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020.

Authors:  Amna Tariq; Yiseul Lee; Kimberlyn Roosa; Seth Blumberg; Ping Yan; Stefan Ma; Gerardo Chowell
Journal:  BMC Med       Date:  2020-06-03       Impact factor: 8.775

7.  Modeling delay to diagnosis for amyotrophic lateral sclerosis: under reporting and incidence estimates.

Authors:  Irene Rocchetti; Domenica Taruscio; Daniela Pierannunzio
Journal:  BMC Neurol       Date:  2012-12-23       Impact factor: 2.474

8.  Real-time monitoring the transmission potential of COVID-19 in Singapore, March 2020.

Authors:  Amna Tariq; Yiseul Lee; Kimberlyn Roosa; Seth Blumberg; Ping Yan; Stefan Ma; Gerardo Chowell
Journal:  medRxiv       Date:  2020-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.